Circadian and sleep phenotypes in a mouse model of Alzheimer's disease characterized by intracellular accumulation of amyloid β oligomers

Exp Anim. 2024 May 3;73(2):186-192. doi: 10.1538/expanim.23-0104. Epub 2023 Dec 14.

Abstract

Disturbances in sleep-wake and circadian rhythms may reportedly precede the onset of cognitive symptoms in the early stages of Alzheimer's disease (AD); however, the underlying mechanisms of these AD-induced sleep disturbances remain unelucidated. To specifically evaluate the involvement of amyloid beta (Aβ) oligomers in AD-induced sleep disturbances, we examined circadian and sleep phenotypes using an Aβ-GFP transgenic (Aβ-GFP Tg) mouse characterized by intracellular accumulation of Aβ oligomers. The circadian rhythm and free-running period of wheel running activity were identical between Aβ-GFP Tg and littermate wild-type mice. The durations of rapid eye movement (REM) sleep were elongated in Aβ-GFP Tg mice; however, the durations of non-REM sleep and wakefulness were unaffected. The Aβ-GFP Tg mice exhibited shifts in the electroencephalogram (EEG) power spectra toward higher frequencies in the inactive light phase. These findings suggest that the intracellular accumulation of Aβ oligomers might be associated with sleep quality; however, its impact on circadian systems is limited.

Keywords: Alzheimer’s disease; amyloid beta; circadian rhythm; sleep.

MeSH terms

  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / physiopathology
  • Amyloid beta-Peptides* / metabolism
  • Animals
  • Circadian Rhythm* / physiology
  • Disease Models, Animal*
  • Electroencephalography
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic*
  • Phenotype*
  • Sleep / physiology
  • Sleep Wake Disorders / etiology
  • Sleep Wake Disorders / metabolism
  • Sleep Wake Disorders / physiopathology
  • Sleep, REM / physiology
  • Wakefulness / physiology

Substances

  • Amyloid beta-Peptides